Lead Product(s): Influenza Vaccine
Therapeutic Area: Infections and Infectious Diseases Product Name: Flucelvax
Highest Development Status: Approved Product Type: Vaccine
Partner/Sponsor/Collaborator: Not Applicable
Deal Size: Not Applicable Upfront Cash: Not Applicable
Deal Type: Not Applicable October 29, 2020
QIVc is developed using the cell-based influenza vaccine manufacturing process, an alternative to egg-based manufacturing. First absolute efficacy study of a cell-based seasonal influenza vaccine in this population.